Chapter 131. Risk-Benefit of Asthma Therapy in Children: Topical Coticosteroids

  1. William W. Busse MD1 and
  2. Stephen T. Holgate BSc, MD, FRCP2
  1. Pedersen Soren

Published Online: 16 APR 2008

DOI: 10.1002/9780470694923.ch61

Asthma and Rhinitis, Second Edition

Asthma and Rhinitis, Second Edition

How to Cite

Soren, P. (2000) Risk-Benefit of Asthma Therapy in Children: Topical Coticosteroids, in Asthma and Rhinitis, Second Edition (eds W. W. Busse and S. T. Holgate), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470694923.ch61

Editor Information

  1. 1

    Professor of Medicine Head, Clinical Immunology, University of Wisconsin-Madison Medical School, Department of Medicine, Madison Wisconsin, USA

  2. 2

    Clinical Professor of Immuno-Pharmacology, Medical Specialties, Southampton General Hospital, Youthampton, UK

Publication History

  1. Published Online: 16 APR 2008
  2. Published Print: 1 JAN 2000

ISBN Information

Print ISBN: 9780632041756

Online ISBN: 9780470694923

SEARCH

Keywords:

  • fatty acid;
  • asthma therapy;
  • corticosteroids;
  • pharmacodynamics;
  • lipophilicity

Summary

This chapter contains section titled:

  • Introduction

  • Pharmacokinetics

  • Pharmacodynamics

  • Clinical Effect

  • Risk of Side Effects

  • Optimizing Therapy

  • Summary

  • References